These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29477057)

  • 1. Maintenance proton pump inhibition therapy and risk of oesophageal cancer.
    Brusselaers N; Engstrand L; Lagergren J
    Cancer Epidemiol; 2018 Apr; 53():172-177. PubMed ID: 29477057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer.
    Brusselaers N; Lagergren J; Engstrand L
    Cancer Epidemiol; 2019 Oct; 62():101585. PubMed ID: 31445426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy.
    Holmberg D; Mattsson F; Xie S; Ness-Jensen E; El-Serag H; Lagergren J
    J Gastroenterol; 2022 Dec; 57(12):942-951. PubMed ID: 36258093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.
    Chandanos E; Lindblad M; Jia C; Rubio CA; Ye W; Lagergren J
    Br J Cancer; 2006 Jul; 95(1):118-22. PubMed ID: 16755290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
    Brusselaers N; Lagergren J
    BMJ Open; 2018 Jul; 8(7):e021869. PubMed ID: 29982219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.
    García Rodríguez LA; Lagergren J; Lindblad M
    Gut; 2006 Nov; 55(11):1538-44. PubMed ID: 16785284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.
    Hvid-Jensen F; Pedersen L; Funch-Jensen P; Drewes AM
    Aliment Pharmacol Ther; 2014 May; 39(9):984-91. PubMed ID: 24617286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden.
    Brusselaers N; Sadr-Azodi O; Engstrand L
    J Gastroenterol; 2020 Apr; 55(4):453-461. PubMed ID: 31811561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance proton pump inhibitor use and risk of colorectal cancer: a Swedish retrospective cohort study.
    Liu Q; Wang X; Engstrand L; Sadr-Azodi O; Fall K; Brusselaers N
    BMJ Open; 2024 Jul; 14(7):e079591. PubMed ID: 38960460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study.
    Xie SH; Santoni G; Lagergren J
    Br J Cancer; 2022 Jan; 126(1):129-133. PubMed ID: 34671128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.
    Kamal H; Sadr-Azodi O; Engstrand L; Brusselaers N
    Hepatology; 2021 Oct; 74(4):2021-2031. PubMed ID: 34018229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer.
    Lindner K; Borchardt C; Schöpp M; Bürgers A; Stock C; Hussey DJ; Haier J; Hummel R
    J Exp Clin Cancer Res; 2014 Sep; 33(1):73. PubMed ID: 25175076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
    Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
    BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupation and risk of oesophageal adenocarcinoma and squamous-cell carcinoma: The Nordic Occupational Cancer Study.
    Jansson C; Oh JK; Martinsen JI; Lagergren J; Plato N; Kjaerheim K; Pukkala E; Sparén P; Tryggvadottir L; Weiderpass E
    Int J Cancer; 2015 Aug; 137(3):590-7. PubMed ID: 25557854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance Proton Pump Inhibitor Use Associated with Increased All-Cause and Cause-Specific Mortality in Sweden.
    Ngwenya S; Simin J; Brusselaers N
    Dig Dis Sci; 2023 Jun; 68(6):2252-2263. PubMed ID: 36629968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation.
    Giannini EG; Crespi M; Djahandideh A; Demarzo MG; Moscatelli A; Bodini G; Furnari M; Marabotto E; Plaz Torres MC; Zentilin P; Savarino V
    Dig Liver Dis; 2020 Aug; 52(8):862-868. PubMed ID: 32505566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study.
    Kauppila JH; Mattsson F; Brusselaers N; Lagergren J
    BMJ Open; 2018 May; 8(5):e021495. PubMed ID: 29748347
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.